Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET)

Psychiatry Research

Volumn 143, Issue 1, 2006, Pages 13-19

  Rybakowski, Janusz K ^a   Borkowska, Alina ^b   Czerski, Piotr M ^a   Dmitrzak Weglarz, Monika ^a   Skibinska, Maria ^a   Kapelski, Pawel ^a   Hauser, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Catechol O methyltransferase (COMT); Dopamine transporter (DAT); Gene polymorphism; Norepinephrine transporter (NET); Schizophrenia; Wisconsin Card Sorting Test

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE TRANSPORTER; METHIONINE; NORADRENALIN TRANSPORTER; VALINE;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENTAL PATIENT; NEUROPATHOLOGY; PERSEVERATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; VARIABLE NUMBER OF TANDEM REPEAT; WISCONSIN CARD SORTING TEST;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; COGNITION DISORDERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 33744511562     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2005.10.008     Document Type: Article

References (43)

1. Abi-Dargham A., and Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003) 404-416
2. Bertolino A., Caforio G., Blasi G., De Candia M., Lattore V., Petruzzella V., Altamura C., Naddi G., Papa S., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., and Nardini M. Interaction of COMT (Val (108/158) Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. American Journal of Psychiatry 161 (2004) 1798-1805
3. Bilder M.R., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., Goldman R.S., Hoptman M.J., Sheitman B., Lindenmayer J., Citrome L., McEvoy J.P., Kunz M., Chakos M., Cooper T.B., and Lieberman J.A. Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia. Biological Psychiatry 52 (2002) 701-707
4. Bruder G., Keilp J., Xu H., Shikman M., Schori E., Gorman J., and Gilliam T.C. Genetics of working memory and executive function: findings for COMT genotypes. Biological Psychiatry 55 (2004) 35
5. Cohn C.K., and Axelrod J. The effect of estradiol on catechol-O-methyltransferase activity in rat liver. Life Sciences 10 (1971) 1351-1354
6. 108/158 Met phenotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 6917-6922
7. Everett J., Lavoie K., Gagnon J.-F., and Gosselin N. Performance of patients with schizophrenia on the Wisconsin Card Sorting Test (WCST). Journal of Psychiatry & Neuroscience 26 (2001) 123-130
8. Faraone S.V., Seidman L.J., Kremen W.S., Pepple J.R., Lyons M.J., and Tsuang M.T. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. Journal of Abnormal Psychology 104 (1995) 286-304
9. First M.B., Spitzer R.L., Gibbon M., and Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) (1996), American Psychiatric Press Inc., Washington, DC
10. Franke P., Maier W., Hain C., and Klinger T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?. Schizophrenia Research 6 (1992) 243-249
11. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., and Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 9991-9996
12. 1 receptors in prefrontal cells and circuits. Brain Research Reviews 31 (2000) 295-301
13. Hauser J., Kapelski P., Czerski P.M., Godlewski S., Dmitrzak-Weglarz M., Twardowska K., and Rybakowski J.K. Lack of association between VNTR polymorphism of DAT gene and schizophrenia [in Polish]. Psychiatria Polska 36 (2002) 403-412
14. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtis G. Wisconsin Card Sorting Test Manual (1993), Psychological Assessment Resources, Odessa, FL
15. Herken H., and Erdal M.E. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatric Genetics 11 (2001) 105-109
16. Jönsson E.G., Nöthen M.M., Gustavsson P.J., Neidt H., Bunzel R., Propping P., and Sedvall G.C. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Research 79 (1998) 1-9
17. Karoum F., Chrapusta S.J., and Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Journal of Neurochemistry 63 (1994) 972-979
18. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
19. Leszczynska-Rodziewicz A., Czerski P.M., Kapelski P., Godlewski S., Dmitrzk-Weglarz M., Rybakowski J., and Hauser J. A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 45 (2002) 182-185
20. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., Liu X., and Collier D.A. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatric Genetics 6 (1996) 131-133
21. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Menen K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
22. Miller S.A., Dykaes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Research 16 (1988) 1215
23. Moron J.A., Brockington A., Wise R.A., Rocha B.A., and Hope B.T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. Journal of Neuroscience 22 (2002) 389-395
24. Ohmori O., Shinkai T., Kojima H., Terao T., Suzuki T., Mita T., and Abe K. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neuroscience Letters 243 (1998) 109-112
25. Persico A.M., and Macciardi F. Genotypic association between dopamine transporter gene polymorphism and schizophrenia. American Journal of Medical Genetics 74 (1997) 53-57
26. Rybakowski J.K., and Borkowska A. Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patients. Schizophrenia Research 54 (2002) 105-110
27. Rybakowski J., Borkowska A., Czerski P., and Hauser J. Eye movement disturbances in schizophrenia and a polymorphism of the catechol-O-metylotransferase gene. Psychiatry Research 113 (2002) 49-57
28. Sazci A., Ergul E., Kucukali I., Kilic G., Kaya G., and Kara I. Catecho-O-methyltransferase gene Val108/158Met polymorphism and susceptibility to schizophrenia: association is more significant in women. Brain Research: Molecular Brain Research 132 (2004) 51-56
29. Semwal P., Prasad S., Bhatia T., Desphande S.N., Wodo J., Nimgaonkar V.L., and Thelma D. Family-based association studies of monoaminergic gene polymorphism among North Indians with schizophrenia. Molecular Psychiatry 6 (2001) 220-224
30. Shansky R.M., Glavis-Bloom C., Lerman D., McRae P., Benson C., Miller K., Cosand L., Horvath T.L., and Arnsten A.F. Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Molecular Psychiatry 9 (2004) 531-538
31. Shifman S., Bronstein M., Sternfeld M., Pisanté-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vaneti M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., and Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics 71 (2002) 1296-1302
32. 158met genotype associated with schizotypy: a population study of 543 young men. Biological Psychiatry 56 (2004) 510-515
33. Strous R.D., Nolan K.A., Lapidus R., Diaz L., Saito T., and Lachman H.M. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. American Journal of Medical Genetics 120B (2003) 29-34
34. Szekeres G., Keri S., Juhasz A., Rimanoczy A., Szendi I., Czimmer C., and Janka Z. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to antipsychotics in patients with schizophrenia. American Journal of Medical Genetics 124B (2004) 1-5
35. Tsai S.J., Yu Y.W., Chen T.J., Liou Y.J., Chen M.C., and Hong C.J. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neuroscience Letters 338 (2003) 123-126
36. Tsai S.J., Hong C.J., Liao D.L., Lai I.C., and Liou Y.J. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology 49 (2004) 196-200
37. Vandenberg D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., and Uhl G.R. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14 4 (1992) 1104-1106
38. Van der Does A.J.W., and Van den Bosch R.J. What determines Wisconsin Card Sorting Test performance in schizophrenia?. Clinical Psychology Review 12 (1992) 567-583
39. VanNess S.H., Owens M.J., and Kitts C.D. The 3′VNTR element in DAT1 regulates in vitro DAT binding site density. Biological Psychiatry 55 (2004) 34
40. Weickert T.W., Goldberg T.E., Mishara A., Apud J.A., Kolachana B.S., Egan M.F., and Weinberger D.R. Catechol-O-methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medications. Biological Psychiatry 56 (2004) 677-682
41. Weinberger D.R., Berman K.F., and Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral flow evidence. Archives of General Psychiatry 43 (1986) 114-124
42. Wonodi I., Stine O.C., Mitchell B.D., and Buchanan R.W. Association between Val108/158Met polymorphism of the COMT gene and schizophrenia. American Journal of Medical Genetics 120B (2003) 47-50
43. Zinkstok J., de Wide O., van Amelsvoort T., Baas F., and Linszen D. The catechol-O-methyltranspferase gene and working memory in recent onset schizophrenia. American Journal of Medical Genetics 130B (2004) 59